Abstract

Seco-chaetomugilins A and D were isolated from a strain of Chaetomium globosum that was originally isolated from the marine fish Mugil cephalus, and their absolute stereostructures were elucidated on the basis of spectroscopic analyses, including 1D and 2D NMR techniques, along with the chemical transformation from known chaetomugilins A and D. Seco-chaetomugilin D exhibited growth inhibitory activity against cultured P388, HL-60, L1210, and KB cells.

Highlights

  • Marine microorganisms are potentially prolific sources of highly bioactive secondary metabolites that might serve as useful leads in the development of new pharmaceutical agents

  • Based on the fact that some of the bioactive materials isolated from marine animals have been produced by bacteria, we have focused our attention on new antitumor agents from microorganisms separated from marine organisms [1,2,3,4,5]

  • As part of this endeavor, we have conducted a search for antitumor compounds from a strain of Chaetomium globosum OUPS-T106B-6 that was originally isolated from the marine fish

Read more

Summary

Introduction

Marine microorganisms are potentially prolific sources of highly bioactive secondary metabolites that might serve as useful leads in the development of new pharmaceutical agents. Our continuing search for cytotoxic metabolites from this fungal strain yielded two new azaphilones designated as seco-chaetomugilins A (3) and D (4) (Figure 1). The AcOEt extract of the culture filtrate was purified by bioassay-directed fractionation (cytotoxicities against P388 cell line) employing a stepwise combination of Sephadex LH-20, silica gel column chromatography, and reversed-phase HPLC (RP-HPLC) to afford seco-chaetomugilins A (3)

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.